Tharimmune (THAR) Stock Price, News, Quotes-Moomoo

US Stock MarketDetailed Quotes

THAR Tharimmune

Watchlist

2.460
-0.150-5.75%

Trading Nov 22 09:47 ET

3.66MMarket Cap0.04P/E (TTM)

Intraday

5D
Daily
Weekly
Monthly
1Q
1Y

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

Tharimmune Abandons Acquisition of Intract Pharma
WSJ18:08 ET
Express News | Tharimmune Inc - Increases Board Size to Six
Reuters16:55 ET
What's Going On With Tharimmune Shares Monday?
BenzingaNov 18 11:47 ET
Express News | Tharimmune Shares Are Trading Higher After the Company Announced It Will Present at the 75th AASLD Liver Meeting
BenzingaNov 18 08:23 ET
Tharimmune Presents Positive Clinical Data at AASLD the Liver Meeting(R) to Support TH104 for Chronic Pruritus in Chronic Liver Disease
AccesswireNov 18 08:00 ET
Tharimmune Granted Patent for Delivery of Molecularly Targeted Therapeutics
TipRanksNov 13 08:57 ET

Comments

Jaguar8

Nov 18 09:44

NEWS PM

$Tharimmune (THAR.US)$
Tharimmune Presents Positive Clinical Data at AASLD the Liver Meeting(R) to Support TH104 for Chronic Pruritus in Chronic Liver Disease
Tharimmune (NASDAQ:THAR) presented Phase 1 clinical data for TH104 at AASLD The Liver Meeting 2024. The trial evaluated TH104 transmucosal buccal film in patients with chronic liver disease (CLD) for chronic pruritus treatment.
The study showed significant correlation between blood levels and symptom relief, with a correlation coeff...

George Soros II

Nov 18 07:09

$Tharimmune (THAR.US)$

70981574

Nov 18 07:06

$Tharimmune (THAR.US)$ No News, why is pumping ? Manipulation again ??

Jaguar8

Nov 13 07:03

NEWS

$Tharimmune (THAR.US)$
Tharimmune Granted European Patent for Delivery of Optimized Molecularly Targeted Therapeutics
Tharimmune (NASDAQ:THAR) has been granted a European patent for biodegradable polymeric nanoparticles designed to deliver therapeutic antibodies and peptides. The technology aims to enhance drug delivery by improving stability and reducing systemic side effects, particularly in cancer therapies. The nanoparticles feature tunable size, non-toxic profiles, and extended drug hal...

puan kalsom

Oct 31 10:01

$Tharimmune (THAR.US)$

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall

No Data

THAR Tharimmune

Trade Overview

Capital Trend

News

Comments

Analysis

Analyst Rating

Price Target